Table of Content

1 Impotence Agents Market Overview
1.1 Product Overview and Scope of Impotence Agents
1.2 Impotence Agents Segment by Type
1.2.1 Global Impotence Agents Market Value Comparison by Type (2024-2034)
1.2.2 Oral Preparation
1.2.3 Injection
1.2.4 Other
1.3 Impotence Agents Segment by Application
1.3.1 Global Impotence Agents Market Value by Application: (2024-2034)
1.3.2 Erectile Dysfunction
1.3.3 Premature Ejaculation
1.3.4 Other
1.4 Global Impotence Agents Market Size Estimates and Forecasts
1.4.1 Global Impotence Agents Revenue 2018-2029
1.4.2 Global Impotence Agents Sales 2018-2029
1.4.3 Global Impotence Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Impotence Agents Market Competition by Manufacturers
2.1 Global Impotence Agents Sales Market Share by Manufacturers (2018-2024)
2.2 Global Impotence Agents Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Impotence Agents Average Price by Manufacturers (2018-2024)
2.4 Global Impotence Agents Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Impotence Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Impotence Agents, Product Type & Application
2.7 Impotence Agents Market Competitive Situation and Trends
2.7.1 Impotence Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Impotence Agents Players Market Share by Revenue
2.7.3 Global Impotence Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Impotence Agents Retrospective Market Scenario by Region
3.1 Global Impotence Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Impotence Agents Global Impotence Agents Sales by Region: 2018-2029
3.2.1 Global Impotence Agents Sales by Region: 2018-2024
3.2.2 Global Impotence Agents Sales by Region: 2024-2029
3.3 Global Impotence Agents Global Impotence Agents Revenue by Region: 2018-2029
3.3.1 Global Impotence Agents Revenue by Region: 2018-2024
3.3.2 Global Impotence Agents Revenue by Region: 2024-2029
3.4 North America Impotence Agents Market Facts & Figures by Country
3.4.1 North America Impotence Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Impotence Agents Sales by Country (2018-2029)
3.4.3 North America Impotence Agents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Impotence Agents Market Facts & Figures by Country
3.5.1 Europe Impotence Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Impotence Agents Sales by Country (2018-2029)
3.5.3 Europe Impotence Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Impotence Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Impotence Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Impotence Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Impotence Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Impotence Agents Market Facts & Figures by Country
3.7.1 Latin America Impotence Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Impotence Agents Sales by Country (2018-2029)
3.7.3 Latin America Impotence Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Impotence Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Impotence Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Impotence Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Impotence Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Impotence Agents Sales by Type (2018-2029)
4.1.1 Global Impotence Agents Sales by Type (2018-2024)
4.1.2 Global Impotence Agents Sales by Type (2024-2029)
4.1.3 Global Impotence Agents Sales Market Share by Type (2018-2029)
4.2 Global Impotence Agents Revenue by Type (2018-2029)
4.2.1 Global Impotence Agents Revenue by Type (2018-2024)
4.2.2 Global Impotence Agents Revenue by Type (2024-2029)
4.2.3 Global Impotence Agents Revenue Market Share by Type (2018-2029)
4.3 Global Impotence Agents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Impotence Agents Sales by Application (2018-2029)
5.1.1 Global Impotence Agents Sales by Application (2018-2024)
5.1.2 Global Impotence Agents Sales by Application (2024-2029)
5.1.3 Global Impotence Agents Sales Market Share by Application (2018-2029)
5.2 Global Impotence Agents Revenue by Application (2018-2029)
5.2.1 Global Impotence Agents Revenue by Application (2018-2024)
5.2.2 Global Impotence Agents Revenue by Application (2024-2029)
5.2.3 Global Impotence Agents Revenue Market Share by Application (2018-2029)
5.3 Global Impotence Agents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Inc Impotence Agents Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Bayer AG
6.2.1 Bayer AG Corporation Information
6.2.2 Bayer AG Description and Business Overview
6.2.3 Bayer AG Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bayer AG Impotence Agents Product Portfolio
6.2.5 Bayer AG Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Novartis AG Impotence Agents Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Hikma Pharmaceuticals plc
6.4.1 Hikma Pharmaceuticals plc Corporation Information
6.4.2 Hikma Pharmaceuticals plc Description and Business Overview
6.4.3 Hikma Pharmaceuticals plc Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hikma Pharmaceuticals plc Impotence Agents Product Portfolio
6.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Aurobindo Pharma Impotence Agents Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 VIVUS LLC.
6.6.1 VIVUS LLC. Corporation Information
6.6.2 VIVUS LLC. Description and Business Overview
6.6.3 VIVUS LLC. Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.6.4 VIVUS LLC. Impotence Agents Product Portfolio
6.6.5 VIVUS LLC. Recent Developments/Updates
6.7 Petros Pharmaceuticals, Inc.
6.6.1 Petros Pharmaceuticals, Inc. Corporation Information
6.6.2 Petros Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Petros Pharmaceuticals, Inc. Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Petros Pharmaceuticals, Inc. Impotence Agents Product Portfolio
6.7.5 Petros Pharmaceuticals, Inc. Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Corporation Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bristol-Myers Squibb Company Impotence Agents Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 GSK PLC
6.9.1 GSK PLC Corporation Information
6.9.2 GSK PLC Description and Business Overview
6.9.3 GSK PLC Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.9.4 GSK PLC Impotence Agents Product Portfolio
6.9.5 GSK PLC Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sanofi Impotence Agents Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Teva Pharmaceuticals Industries Ltd
6.11.1 Teva Pharmaceuticals Industries Ltd Corporation Information
6.11.2 Teva Pharmaceuticals Industries Ltd Impotence Agents Description and Business Overview
6.11.3 Teva Pharmaceuticals Industries Ltd Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Teva Pharmaceuticals Industries Ltd Impotence Agents Product Portfolio
6.11.5 Teva Pharmaceuticals Industries Ltd Recent Developments/Updates
6.12 Lilly
6.12.1 Lilly Corporation Information
6.12.2 Lilly Impotence Agents Description and Business Overview
6.12.3 Lilly Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Lilly Impotence Agents Product Portfolio
6.12.5 Lilly Recent Developments/Updates
6.13 Adamed
6.13.1 Adamed Corporation Information
6.13.2 Adamed Impotence Agents Description and Business Overview
6.13.3 Adamed Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Adamed Impotence Agents Product Portfolio
6.13.5 Adamed Recent Developments/Updates
6.14 Sun Pharmaceutical Industries, Ltd.
6.14.1 Sun Pharmaceutical Industries, Ltd. Corporation Information
6.14.2 Sun Pharmaceutical Industries, Ltd. Impotence Agents Description and Business Overview
6.14.3 Sun Pharmaceutical Industries, Ltd. Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Sun Pharmaceutical Industries, Ltd. Impotence Agents Product Portfolio
6.14.5 Sun Pharmaceutical Industries, Ltd. Recent Developments/Updates
6.15 Auxilium Pharmaceuticals, Inc.
6.15.1 Auxilium Pharmaceuticals, Inc. Corporation Information
6.15.2 Auxilium Pharmaceuticals, Inc. Impotence Agents Description and Business Overview
6.15.3 Auxilium Pharmaceuticals, Inc. Impotence Agents Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Auxilium Pharmaceuticals, Inc. Impotence Agents Product Portfolio
6.15.5 Auxilium Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Impotence Agents Industry Chain Analysis
7.2 Impotence Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Impotence Agents Production Mode & Process
7.4 Impotence Agents Sales and Marketing
7.4.1 Impotence Agents Sales Channels
7.4.2 Impotence Agents Distributors
7.5 Impotence Agents Customers
8 Impotence Agents Market Dynamics
8.1 Impotence Agents Industry Trends
8.2 Impotence Agents Market Drivers
8.3 Impotence Agents Market Challenges
8.4 Impotence Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Impotence Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Impotence Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Impotence Agents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Impotence Agents Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Impotence Agents Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Impotence Agents Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Impotence Agents Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Impotence Agents Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Impotence Agents, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Impotence Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Impotence Agents, Product Type & Application
Table 12. Global Key Manufacturers of Impotence Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Impotence Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Impotence Agents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Impotence Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Impotence Agents Sales by Region (2018-2024) & (K Units)
Table 18. Global Impotence Agents Sales Market Share by Region (2018-2024)
Table 19. Global Impotence Agents Sales by Region (2024-2029) & (K Units)
Table 20. Global Impotence Agents Sales Market Share by Region (2024-2029)
Table 21. Global Impotence Agents Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Impotence Agents Revenue Market Share by Region (2018-2024)
Table 23. Global Impotence Agents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Impotence Agents Revenue Market Share by Region (2024-2029)
Table 25. North America Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 27. North America Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 28. North America Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 32. Europe Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 33. Europe Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Impotence Agents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Impotence Agents Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Impotence Agents Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Impotence Agents Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Impotence Agents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Impotence Agents Sales (K Units) by Type (2018-2024)
Table 51. Global Impotence Agents Sales (K Units) by Type (2024-2029)
Table 52. Global Impotence Agents Sales Market Share by Type (2018-2024)
Table 53. Global Impotence Agents Sales Market Share by Type (2024-2029)
Table 54. Global Impotence Agents Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Impotence Agents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Impotence Agents Revenue Market Share by Type (2018-2024)
Table 57. Global Impotence Agents Revenue Market Share by Type (2024-2029)
Table 58. Global Impotence Agents Price (US$/Unit) by Type (2018-2024)
Table 59. Global Impotence Agents Price (US$/Unit) by Type (2024-2029)
Table 60. Global Impotence Agents Sales (K Units) by Application (2018-2024)
Table 61. Global Impotence Agents Sales (K Units) by Application (2024-2029)
Table 62. Global Impotence Agents Sales Market Share by Application (2018-2024)
Table 63. Global Impotence Agents Sales Market Share by Application (2024-2029)
Table 64. Global Impotence Agents Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Impotence Agents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Impotence Agents Revenue Market Share by Application (2018-2024)
Table 67. Global Impotence Agents Revenue Market Share by Application (2024-2029)
Table 68. Global Impotence Agents Price (US$/Unit) by Application (2018-2024)
Table 69. Global Impotence Agents Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Inc Corporation Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Inc Impotence Agents Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Business Overview
Table 77. Bayer AG Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Bayer AG Impotence Agents Product
Table 79. Bayer AG Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Novartis AG Impotence Agents Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Hikma Pharmaceuticals plc Corporation Information
Table 86. Hikma Pharmaceuticals plc Description and Business Overview
Table 87. Hikma Pharmaceuticals plc Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Hikma Pharmaceuticals plc Impotence Agents Product
Table 89. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Aurobindo Pharma Impotence Agents Product
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. VIVUS LLC. Corporation Information
Table 96. VIVUS LLC. Description and Business Overview
Table 97. VIVUS LLC. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. VIVUS LLC. Impotence Agents Product
Table 99. VIVUS LLC. Recent Developments/Updates
Table 100. Petros Pharmaceuticals, Inc. Corporation Information
Table 101. Petros Pharmaceuticals, Inc. Description and Business Overview
Table 102. Petros Pharmaceuticals, Inc. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Petros Pharmaceuticals, Inc. Impotence Agents Product
Table 104. Petros Pharmaceuticals, Inc. Recent Developments/Updates
Table 105. Bristol-Myers Squibb Company Corporation Information
Table 106. Bristol-Myers Squibb Company Description and Business Overview
Table 107. Bristol-Myers Squibb Company Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bristol-Myers Squibb Company Impotence Agents Product
Table 109. Bristol-Myers Squibb Company Recent Developments/Updates
Table 110. GSK PLC Corporation Information
Table 111. GSK PLC Description and Business Overview
Table 112. GSK PLC Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GSK PLC Impotence Agents Product
Table 114. GSK PLC Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Sanofi Impotence Agents Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Teva Pharmaceuticals Industries Ltd Corporation Information
Table 121. Teva Pharmaceuticals Industries Ltd Description and Business Overview
Table 122. Teva Pharmaceuticals Industries Ltd Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Teva Pharmaceuticals Industries Ltd Impotence Agents Product
Table 124. Teva Pharmaceuticals Industries Ltd Recent Developments/Updates
Table 125. Lilly Corporation Information
Table 126. Lilly Description and Business Overview
Table 127. Lilly Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Lilly Impotence Agents Product
Table 129. Lilly Recent Developments/Updates
Table 130. Adamed Corporation Information
Table 131. Adamed Description and Business Overview
Table 132. Adamed Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Adamed Impotence Agents Product
Table 134. Adamed Recent Developments/Updates
Table 135. Sun Pharmaceutical Industries, Ltd. Corporation Information
Table 136. Sun Pharmaceutical Industries, Ltd. Description and Business Overview
Table 137. Sun Pharmaceutical Industries, Ltd. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Sun Pharmaceutical Industries, Ltd. Impotence Agents Product
Table 139. Sun Pharmaceutical Industries, Ltd. Recent Developments/Updates
Table 140. Auxilium Pharmaceuticals, Inc. Corporation Information
Table 141. Auxilium Pharmaceuticals, Inc. Description and Business Overview
Table 142. Auxilium Pharmaceuticals, Inc. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Auxilium Pharmaceuticals, Inc. Impotence Agents Product
Table 144. Auxilium Pharmaceuticals, Inc. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Impotence Agents Distributors List
Table 148. Impotence Agents Customers List
Table 149. Impotence Agents Market Trends
Table 150. Impotence Agents Market Drivers
Table 151. Impotence Agents Market Challenges
Table 152. Impotence Agents Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Impotence Agents
Figure 2. Global Impotence Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Impotence Agents Market Share by Type in 2022 & 2029
Figure 4. Oral Preparation Product Picture
Figure 5. Injection Product Picture
Figure 6. Other Product Picture
Figure 7. Global Impotence Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Impotence Agents Market Share by Application in 2022 & 2029
Figure 9. Erectile Dysfunction
Figure 10. Premature Ejaculation
Figure 11. Other
Figure 12. Global Impotence Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Impotence Agents Market Size (2018-2029) & (US$ Million)
Figure 14. Global Impotence Agents Sales (2018-2029) & (K Units)
Figure 15. Global Impotence Agents Average Price (US$/Unit) & (2018-2029)
Figure 16. Impotence Agents Report Years Considered
Figure 17. Impotence Agents Sales Share by Manufacturers in 2022
Figure 18. Global Impotence Agents Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Impotence Agents Players: Market Share by Revenue in 2022
Figure 20. Impotence Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Impotence Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Impotence Agents Sales Market Share by Country (2018-2029)
Figure 23. North America Impotence Agents Revenue Market Share by Country (2018-2029)
Figure 24. United States Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Impotence Agents Sales Market Share by Country (2018-2029)
Figure 27. Europe Impotence Agents Revenue Market Share by Country (2018-2029)
Figure 28. Germany Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Impotence Agents Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Impotence Agents Revenue Market Share by Region (2018-2029)
Figure 35. China Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Impotence Agents Sales Market Share by Country (2018-2029)
Figure 43. Latin America Impotence Agents Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Impotence Agents Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Impotence Agents Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Impotence Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Impotence Agents by Type (2018-2029)
Figure 53. Global Revenue Market Share of Impotence Agents by Type (2018-2029)
Figure 54. Global Impotence Agents Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Impotence Agents by Application (2018-2029)
Figure 56. Global Revenue Market Share of Impotence Agents by Application (2018-2029)
Figure 57. Global Impotence Agents Price (US$/Unit) by Application (2018-2029)
Figure 58. Impotence Agents Value Chain
Figure 59. Impotence Agents Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed